InvestorsHub Logo
Followers 47
Posts 12038
Boards Moderated 0
Alias Born 09/12/2017

Re: Monroe1 post# 230616

Tuesday, 03/05/2024 10:06:43 PM

Tuesday, March 05, 2024 10:06:43 PM

Post# of 232960
It used to be bankruptcy--- Since our inception, we have been insolvent and have required debt and equity financing to maintain operations.
https://www.sec.gov/Archives/edgar/data/1175680/000155837023015718/cydy-20230531x10k.htm

there won't be a new CEO--- A guy whos been affiliated with the co since at least 2006 and the co owes $400K to.
https://www.biospace.com/article/releases/cytodyn-selects-b-quest-clinical-research-b-for-next-trial-of-hiv-aids-immune-therapy-/

Since June 1, 2021, the Company has paid Quest approximately $1.5 million for its services in conducting clinical trials of leronlimab. As of November 17, 2023, the outstanding balance owed by the Company to Quest was approximately $0.4 million.
https://www.sec.gov/Archives/edgar/data/1175680/000155837023019285/cydy-20231117x8k.htm

then they said no holds will be lifted--- Wheres that detailed 8K filing?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News